Browsing by Author Sullivan, David

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 20 of 86  next >
Issue DateTitleAuthor(s)Citation
2010Adjustment of direct high-density lipoprotein cholesterol measurements according to intercurrent triglyceride corrects for interference by triglyceride-rich lipoproteinsLewis, Barry; Sullivan, David; Burns, Jennifer C; Perera, N.J.; Perera, Ryle; Central Clinical School: Medicine; School of Molecular BioscienceAdjustment of direct high-density lipoprotein cholesterol measurements according to intercurrent triglyceride corrects for interference by triglyceride-rich lipoproteins, Journal of Clinical Lipidology, vol.4, 4,pp 305-309
2005Age-related changes in the hepatic sinusoidal endothelium impede lipoprotein transfer in the rat.Cogger, Victoria; Hilmer, Sarah; Le Couteur, David; Sullivan, David; Fraser, Robin; McLean, Allan J.; Concord Clinical School: ANZAC Research Institute; Concord Clinical School: ANZAC Research Institute; Concord Clinical School: ANZAC Research Institute; Molecular & Microbial BioscienAge-related changes in the hepatic sinusoidal endothelium impede lipoprotein transfer in the rat., Hepatology, vol.42,(6),2005,pp 1349-1354
2006Aging, atheroscleroisis and the liver sieveCogger, Victoria; Harris, Matthew; Hilmer, Sarah; Le Couteur, David; Muller, Michael; Sullivan, David; Fraser, R; McLean, Andrew J; Concord Clinical School: ANZAC Research Institute; Concord Clinical School: ANZAC Research Institute; Concord Clinical School: ANZAC Research Institute; Concord Clinical School: ANZAC Research Institute; Concord Clinical School: ANZAC Research Institute; Molecular & Microbial BioscienAging, atheroscleroisis and the liver sieve in New research on atherosclerosis, Nova Science Publishers Inc, 2006, pp. 19-44
2014Anti-PCSK9 Antibody Effectively Lowers Cholesterol in Patients with Statin Intolerance: The GAUSS-2 Randomized, Placebo-controlled Phase 3 Clinical Trial of EvolocumabSullivan, David; Bruckert, Eric; Cho, Leslie; Civeira, Fernando; Colquhoun, David; Dent, Ricardo; et al, Various; Knusel, Beat; Rosenson, Robert S; Stroes, Erik; Watts, Gerald F; School of Public Health: NH&MRC Clinical Trials CentreAnti-PCSK9 Antibody Effectively Lowers Cholesterol in Patients with Statin Intolerance: The GAUSS-2 Randomized, Placebo-controlled Phase 3 Clinical Trial of Evolocumab, Journal of the American College of Cardiology, vol.63, 23, 2014,pp 2541-2548
2004Apolipoprotein A-I-Stimulated Apolipoprotein E Secretion From Human Macrophages Is Independent Of Cholesterol Efflux.Kritharides, Leonard; Rye, Kerry-Anne; Sullivan, David; Anantharamaiah, G M; Assmann, Gerd; Burnett, John R; Dean, Roger T; Fu, Ying; Gaus, Katharina; Jessup, Wendy; Katz, Sissel Lund; Kockx, Maaike; Palgunachari, Mayakonda N; Phillips, Michael C; Quinn, Carmel M; Rust, Stephan; Sloane, Timothy; Sviridov, Dimitri; Wright, Janelle; Concord Clinical School: ANZAC Research Institute; Central Clinical School: Heart Research Institute; Molecular & Microbial BioscienApolipoprotein A-I-Stimulated Apolipoprotein E Secretion From Human Macrophages Is Independent Of Cholesterol Efflux., Journal of Biological Chemistry, vol.279,(25),2004,pp 25966-25977
2014Association of Contemporary Sensitive Troponin I Levels at Baseline and Change at 1 Year With Long - Term Coronary Events Following Myocardial Infarction or Unstable AnginaKeech, Anthony (Tony); Mann, Kristy; Simes, Robert John; Blankenberg, Stefan; Colquhoun, David; Hunt, David; Nestel, Paul; Stewart, Ralph A.H.; Sullivan, David; Thompson, Peter; Tonkin, Andrew; West, Malcolm; White, Harvey D.; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials CentreAssociation of Contemporary Sensitive Troponin I Levels at Baseline and Change at 1 Year With Long - Term Coronary Events Following Myocardial Infarction or Unstable Angina, Journal of the American College of Cardiology, vol.63, 4, 2014,pp 345-354
2014Associations between periodontal disease and cardiovascular surrogate measures among Indigenous AustraliansCelermajer, David; Skilton, Michael; Sullivan, David; Bartold, P Mark; Brown, Alex; Do, Loc Giang; Jamieson, Lisa M; Kapellas, Kostas; Maple-Brown, Louise J.; O'Dea, Kerin; Slade, Gary D.; Wang, Hao; Central Clinical School: Medicine; Boden Institute; School of Public Health: NH&MRC Clinical Trials CentreAssociations between periodontal disease and cardiovascular surrogate measures among Indigenous Australians, International Journal of Cardiology, vol.173, 2, 2014,pp 190-196
2011Associations between the use of metformin, sulphonylureas, or diet alone and cardiovascular outcomes in 6005 patients with type 2 diabetes in the FIELD studyDonoghoe, Mark; Forder, Peta; Keech, Anthony (Tony); Kritharides, Leonard; Merrifield, Alistair; Simes, Robert John; Sullivan, David; Colman, P. G.; Haapamäki, Hannu; Neil, Graham; Whiting, Malcolm; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials Centre; Concord Clinical School: ANZAC Research Institute; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials Centre; Molecular BioscienceAssociations between the use of metformin, sulphonylureas, or diet alone and cardiovascular outcomes in 6005 patients with type 2 diabetes in the FIELD study, Diabetes Research and Clinical Practice, vol.94, 2, 2011,pp 284-290
2017Baseline circulating FGF21 concentrations and increase after fenofibrate treatment predict more rapid glycemic progression in type 2 diabetes: Results from the FIELD studyBarter, Philip; Januszewski, Andrzej Szczesny; Jenkins, Alicia; Keech, Anthony (Tony); O'Connell, Rachel; Ong, Kwok; Rye, Kerry-Anne; Simes, Veronica; Sullivan, David; Waldman, Boris; Best, J; Colman, P; Scott, R; Taskinen, Marja-Riitta; Xu, A; Central Clinical School: Heart Research Institute; NH&MRC Clinical Trials Centre; NH&MRC Clinical Trials Centre; NH&MRC Clinical Trials Centre; NH&MRC Clinical Trials Centre; Central Clinical School: Heart Research Institute; Central Clinical School: Heart Research Institute; Plant & Food Sciences; NH&MRC Clinical Trials Centre; NH&MRC Clinical Trials CentreBaseline circulating FGF21 concentrations and increase after fenofibrate treatment predict more rapid glycemic progression in type 2 diabetes: Results from the FIELD study, Clinical Chemistry, vol.63, 7, 2017,pp 1261-1270
2015Biomarkers in stable coronary heart disease, their modulation and cardiovascular risk: The LIPID biomarker studyHague, Wendy; Keech, Anthony (Tony); Kirby, Adrienne; Simes, Robert John; Sullivan, David; Blankenberg, Stefan; Colquhoun, David; Funke-Kaiser, Anne; Hunt, David; Nestel, P; Stewart, Ralph; Thompson, Peter; Tonkin, Andrew; West, Malcolm; White, Harvey; Zeller, Tanja; NH&MRC Clinical Trials Centre; NH&MRC Clinical Trials Centre; NH&MRC Clinical Trials Centre; NH&MRC Clinical Trials Centre; NH&MRC Clinical Trials CentreBiomarkers in stable coronary heart disease, their modulation and cardiovascular risk: The LIPID biomarker study, International Journal of Cardiology, vol.201, N/A, 2015,pp 499-507
2003Butylcholinesterase (BCHE) Genotyping for post-succinylcholine apnea in an Australian populationSullivan, David; Burns, Jennifer C; Nightingale, Brain N; Stewart, Peter M; Yen, Tina; Molecular & Microbial BioscienButylcholinesterase (BCHE) Genotyping for post-succinylcholine apnea in an Australian population, Clinical Chemistry (Washington, DC): international journal of molecular diagnostics and laboratory medicine, vol.49,(8),2003,pp 1297-1308
2013Changes in lipoprotein-associated phospholipase A2 activity predict coronary events and partly account for the treatment effect of pravastatin: results from the Long-Term Intervention with Pravastatin in Ischemic Disease studyBarnes, Elizabeth; Keech, Anthony (Tony); Marschner, Ian (Colin); Simes, Robert John; Sullivan, David; Blankenberg, Stefan; Colquhoun, David; Hunt, David; Nestel, Paul; Stewart, Ralph A.H.; Thompson, Peter; Tonkin, Andrew; West, Malcolm; White, Harvey D.; Zeller, Tanja; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials CentreChanges in lipoprotein-associated phospholipase A2 activity predict coronary events and partly account for the treatment effect of pravastatin: results from the Long-Term Intervention with Pravastatin in Ischemic Disease study, Journal of the American Heart Association, vol.2, 5, 2013,pp 1-12
2016Cholesterol efflux capacity: An introduction for cliniciansAnastasius, Malcolm O; Jessup, Wendy; Kockx, Maaike; Kritharides, Leonard; Sullivan, David; Rye, Kerry-Anne; Western Clinical School: Medicine (Westmead); Concord Clinical School: ANZAC Research Institute; Concord Clinical School: ANZAC Research Institute; Concord Clinical School: ANZAC Research Institute; NH&MRC Clinical Trials CentreCholesterol efflux capacity: An introduction for clinicians, American Heart Journal, vol.180, N/A, 2016,pp 54-63
2004Cholesterol-Lowering Effects Of Plant Sterol Esters Differ In Milk, Yoghurt, Bread And Cereal.Ross, David; Sullivan, David; Annison, G; Cehun, M; Clifton, P M; Erichsen, N; Fassoulakis, A; Nestel, P; Noakes, M; Western Clinical School: Medicine (Westmead); School of Molecular BioscienceCholesterol-Lowering Effects Of Plant Sterol Esters Differ In Milk, Yoghurt, Bread And Cereal., European Journal of Clinical Nutrition, vol.58,(N/A),2004,pp 503-509
2011A classification of lipoprotein disorders: Implications for clinical managementLewis, Barry; Sullivan, David; Central Clinical School: Medicine; Molecular BioscienceA classification of lipoprotein disorders: Implications for clinical management, Clinical Lipidology, vol.6, 3, 2011,pp 327-338
2016Clinical Profile of Statin Intolerance in the Phase 3 GAUSS-2 StudySullivan, David; Cho, Leslie; Colquhoun, David; Dent, Ricardo; Rocco, Michael; Rosenson, Robert S; Scott, Rob; Stroes, Erik; Wasserman, Scott M; Xue, Allen; NH&MRC Clinical Trials CentreClinical Profile of Statin Intolerance in the Phase 3 GAUSS-2 Study, Cardiovascular Drugs and Therapy, vol.30, 3, 2016,pp 297-304
2011Continuous Positive Airway Pressure Reduces Postprandial Lipidemia in Obstructive Sleep Apnea. A Randomised, Placebo Controlled Crossover TrialGrunstein, Ron (Ronald); Liu, Peter; Marshall, Nathaniel; Phillips, Craig; Sullivan, David; Yee, Brendon; Central Clinical School: Woolcock Inst. of Medical Research; Central Clinical School: Woolcock Inst. of Medical Research; Central Clinical School: Medicine; Northern Clinical School: Medicine; Molecular Bioscience; Central Clinical School: Woolcock Inst. of Medical ResearchContinuous Positive Airway Pressure Reduces Postprandial Lipidemia in Obstructive Sleep Apnea. A Randomised, Placebo Controlled Crossover Trial, American Journal of Respiratory and Critical Care Medicine, vol.184, 3, 2011,pp 355-361
2009Costs of managing conditions associated with obesity among Australian teenagers.Aitken, Robert; Booth, Michael; Denney-Wilson, Elizabeth; Dobbins, Timothy; George, Jacob; Hardy, Louise; Cowell, Christopher T.; Okely, Anthony D; Sullivan, David; Medicine; School of Public Health: Public Health; School of Public Health: Public Health; School of Public Health: Public Health; Western Clinical School: Westmead Millennium Institute; School of Public Health: Public HealthCosts of managing conditions associated with obesity among Australian teenagers., Journal of Paediatrics and Child Health, vol.45, 7-8,pp 448-456
2014Design and Rationale of the GAUSS-2 Study Trial: a Double-Blind, Ezetimibe-Controlled Phase 3 Study of the Efficacy and Tolerability of Evolocumab (AMG 145) in Subjects with Hypercholesterolemia Who Are Intolerant of Statin TherapySullivan, David; Cho, Leslie; Colquhoun, David; Dent, Ricardo; Rocco, Michael; Rosenson, Robert S; Scott, Rob; Stroes, Erik; Wasserman, Scott M; Xue, Allen; NH&MRC Clinical Trials CentreDesign and Rationale of the GAUSS-2 Study Trial: a Double-Blind, Ezetimibe-Controlled Phase 3 Study of the Efficacy and Tolerability of Evolocumab (AMG 145) in Subjects with Hypercholesterolemia Who Are Intolerant of Statin Therapy, Clinical Cardiology, vol.37, 3, 2014,pp 131-139
2017Design of the familial hypercholesterolaemia australasia network registry: Creating opportunities for greater international collaborationSullivan, David; Bellgard, Matthew; et al, Various; Hunter, Adam; Lamont, Leanne; Napier, Kathryn; Pang, Jing; Pedrotti, Annette; Radochonski, Maciej; Render, Lee; Walker, Caroline; NH&MRC Clinical Trials CentreDesign of the familial hypercholesterolaemia australasia network registry: Creating opportunities for greater international collaboration, Journal of Atherosclerosis and Thrombosis, vol.24, 10, 2017,pp 1075-1084